Family Medicine · Chino, CA
NPI
1124681580
Since 2019
Specialty
Family Medicine
Code 207Q00000X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
12611 9th St Ste A
Chino, CA, 91710
Phone (909) 331-4473
Groups this clinician bills Medicare through
Medicare paid, 2024
$206K
2,064 services
Medicare patients, 2024
318
Average age 75
Drug cost, 2024
$350K
5,328 prescriptions
Company payments, 2025
$155
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hemalatha Murugan was code 99309 (snf e&m), 904 times for 132 patients. In total Hemalatha Murugan billed 2,064 services in 12 codes, and Medicare paid $206K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Office | 904 | 132 | $91.68 | $83K |
| 99233 Hospital E&M - Subsequent | Facility | 251 | 83 | $99.15 | $25K |
| 99308 SNF E&M | Office | 243 | 86 | $53.15 | $13K |
| 99306 SNF E&M | Office | 161 | 125 | $157.84 | $25K |
| 99497 Care Management/Coordination | Office | 158 | 125 | $72.11 | $11K |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 116 | 96 | $186.46 | $22K |
| 99239 Hospital Discharge Management | Facility | 59 | 57 | $97.38 | $5,745 |
| 99223 Hospital E&M - Initial | Facility | 57 | 57 | $145.14 | $8,273 |
| 99232 Hospital E&M - Subsequent | Facility | 40 | 26 | $67.75 | $2,710 |
| 99291 Critical Care E&M | Facility | 35 | 21 | $178.32 | $6,241 |
| 99497 Care Management/Coordination | Facility | 23 | 23 | $65.14 | $1,498 |
| 99285 Emergency Department E&M | Facility | 15 | 14 | $144.19 | $2,163 |
By year: 2022 $91K for 994 services; 2023 $146K for 1,732 services; 2024 $206K for 2,064 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hemalatha Murugan prescribed most often to Medicare patients was Atorvastatin Calcium, with 276 prescriptions and refills. In total Hemalatha Murugan wrote 5,328 Medicare prescriptions that cost $350K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 276 | 297 | 55 | $3,115 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 198 | 198 | 25 | $3,283 |
| Metoprolol Tartrate Generic | 134 | 140 | 22 | $1,406 |
| Levetiracetam Generic | 132 | 132 | 14 | $3,645 |
| Amlodipine Besylate Generic | 123 | 140 | 28 | $811 |
| Metformin Hcl Generic | 123 | 147 | 20 | $1,051 |
| Potassium Chloride Generic | 107 | 108 | 14 | $4,584 |
| Chlorhexidine Gluconate Generic | 106 | 106 | 13 | $1,322 |
| Famotidine Generic | 104 | 109 | 19 | $1,747 |
| Donepezil Hcl Generic | 100 | 101 | 13 | $894 |
| Furosemide Generic | 99 | 107 | 19 | $671 |
| Memantine Hcl Generic | 98 | 99 | Under 11 | $3,153 |
| Pantoprazole Sodium Generic | 97 | 98 | 23 | $6,767 |
| Eliquis Apixaban | 97 | 98 | 20 | $29K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 91 | 91 | 18 | $3,953 |
Brand drugs: 1,026 claims; generic drugs: 4,279 claims; opioid claims: 272.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hemalatha Murugan $155 ($155 in general payments such as food, travel and fees) from 8 companies. The largest payer was Neurocrine BioSciences, Inc. with $31.23.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 1 | $31.23 |
| Astellas Pharma US Inc 4503.T | 1 | $23.22 |
| Pfizer Inc. PFE | 1 | $19.8 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $19.27 |
| Tonix Medicines, Inc. | 1 | $17.11 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $16.05 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $14.34 |
| GlaxoSmithKline, LLC. GSK | 1 | $14.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.